RPS 2116 - Advances in imaging genitourinary cancer

Total bone diffusion volume on whole-body diffusion-weighted imaging is a strong prognostic marker of disease survival in metastatic castration-resistant prostate cancer

Why we shouldn’t trust CT in the evaluation of bone metastases in patients with metastatic prostate cancer: a comparison between pattern of changes on CT and bone metastases MET-RADS-P classification

Cancer Detection Rates in DWI-upgraded Transition Zone lesions align with risk assessment categories in PI-RADS v2.1: a Systematic Review and Meta-analysis

Evaluation of Arterial Enhancement Fraction and Extracellular Volume Fraction from Dual-Layer Spectral CT for Typing and Grading Renal Cell Carcinoma

Prognostic role of Whole-body MRI (WB-MRI) in patients with metastatic prostate cancer receiving systemic anti-cancer therapy

Prognostic value of WB-MRI derived Bone Marrow Adipose Tissue (BMAT) in bone metastatic prostate cancer patients treated with androgen deprivation + enzalutamide +/- zoledronic acid

Conventional Parameters of Periprostatic Fat on 18F-PSMA-1007 PET/CT: A Novel Biomarker for Predicting High ISUP Grade and Short-Term Prognosis in Prostate Cancer

Decrease in kidney volume predicts loss of renal function in prostate cancer patients receiving LuPSMA treatment

Deep learning-accelerated MRI Imaging in Patients with Prostate Cancer and Benign Prostatic Hyperplasia

Treatment related changes versus recurrence of brain tumours

Feasibility of arterial spin labelling in MRI evaluation of adnexal lesions: A comparative study with dynamic contrast enhancement imaging

Diagnostic Value of MR Fat Quantification in Differentiating Prostate Cancer from Benign Prostatic Hyperplasia